Published On: Mon, Oct 6th, 2014

Revolutions Medical Corp. (OTCMKTS:RMCP): Announced Approval for RevVac™ in Mexico

Revolutions Medical Corp. (OTCMKTS:RMCP) confirmed receipt of notification from the Mexican regulatory agency COFEPRIS that registered and approved the RevVac™ safety syringes. The notification permits the import of all sizes of the RevVac™ syringes into Mexico. Revolutions Medical was working with the local distributor and regulatory agency for the past two years to receive this registration. Its local distributor, ComercializadoraNura provides cutting edge products into the local markets with established presence for about 18 years. The company is hopeful about well-receipt of its safety syringes in one of the largest healthcare markets in the world.

ComercializadoraNura’s President, Oscar Salazar expressed that the recent approval of RevVac™  auto retractable vacuum  safety syringes will help reduce accidental needle stick injuries and spread of infectious diseases.

Revolutions Medical Corp. (OTCMKTS:RMCP)’s RevVac™ operates as a standard conventional syringe and required no additional training for its usage. The device is already approved by the U.S. FDA. Its unique technology prevents reusability of the syringe. RevVac™ leverage patented vacuum technology, bringing to the market lowest cost auto-retractable syringe. In addition, the company also focuses on medical imaging enhancement. Its proprietary software solutions enable medical professionals to use standard MRI images for assistance in diagnostic decisions.

Revolutions Medical Corp. (OTCMKTS:RMCP)’s Chairman and CEO, RondaldWheet, carries nearly 15 years of experience in the investment banking industry. He facilitated many capital campaigns for several small-cap medical companies. In 2002, Mr. Wheet formed a consulting business to advise small-cap businesses on strategic partnerships, capital financing and public offerings. At Revolutions Medical, he successfully led the acquisition of Clear Image and launched the first clinical validation studies for MRI software technology. He played proactive role in expanding the company’s intellectual property portfolio including numerous patents pending. He holds a Bachelor’s in Science Degree in Finance and International Business.

© Copyright 2016 OTC News Magazine. All rights reserved.